MedTrace Logo

Anticardiolipin Autoantibodies and Mortality in Septic Patients

NCT04685278 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-12-28

No results posted yet for this study

Summary

The detection of antiphospholipid antibodies (aPL) is of interest because of their importance in the pathogenesis of arterial or venous thrombosis and their responsibility for a wide spectrum of clinical manifestations such as infection. The aim of the study was to assess the performance of antiphospholipid antibodies biomarker to predict in- hospital mortality in intensive care unit (ICU) septic patient's.

Conditions

  • Morality

Interventions

BIOLOGICAL

Blood samples

Blood samples were collected in dry tubes on days 1, 3, 5, 8 and 10 of hospitalization

Sponsors & Collaborators

  • Military Hospital of Tunis

    lead OTHER

Principal Investigators

  • Iheb Labbene, Pr · Military Hospital of Tunis

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-02-05
Completion
2021-02-15

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04685278 on ClinicalTrials.gov